Search - tctmd.com

Displaying 21 - 40 of 52

Sort: Relevancy | Date

Presentation TCT 2024

Evolution of PCI – Role and Value of Drug-Eluting Balloons

Presenter: Roxana Mehran

October 29, 2024

Presentation TCT 2024

LIMUS as the Drug of Choice for Drug-Eluting Balloons

Presenter: Aloke Finn

October 29, 2024

Presentation TCT 2024

SELUTION SLR™ DEB Case Example from Europe

Presenter: Luigi Salemme

October 29, 2024

Presentation TCT 2024

TCT 455: Quantitative Coronary Dissection Volume After Sirolimus or Paclitaxel Coated Balloon and Lumen Changes at 6 Months: Serial OCT Sub-study of TRANSFORM-I Trial

Presenter: Akihiro Tobe

October 29, 2024

Presentation TCT 2024

TCT 450: Patient and Procedure Characteristics for 1000 Selution SLRTM Sirolimus-Eluting Balloon Procedures

Presenter: Simon Eccleshall

October 29, 2024

Presentation TCT 2024

Current DCB Landscape in the USA: Challenges and Opportunities

Presenter: Azeem Latib

October 28, 2024

Presentation TCT 2024

Sirolimus Coated Balloon Complex Cases Presentations: The TITAN RCT

Presenter: Marco Valgimigli

October 28, 2024

Presentation TCT 2024

Case Presentation: DEB in ISR LMCA bifurcation

Presenter: Prathap Kumar

October 28, 2024

Presentation TCT 2024

Global Clinical Experience: MagicTouch SCB in Action: An overview of EASTBOURNE, PICCOLLETO VI, and TRANSFORM

Presenter: Bernardo Cortese

October 28, 2024

Presentation TCT 2024

TCT 44: Angiographic and Clinical Impact of Balloon Inflation Time in Percutaneous Coronary Interventions With Sirolimus-Coated Balloon: A Subanalysis of the EASTBOURNE Study

Presenter: Filippo Luca Gurgoglione

October 28, 2024

Presentation TCT 2024

TCT 41: Paclitaxel-Coated Versus Sirolimus-Coated Balloon Angioplasty for Coronary Artery Disease: A Systematic Review and Meta-Analysis

Presenter: Doosup Shin

October 28, 2024

Presentation TCT 2024

TCT 40: Sirolimus- vs. Paclitaxel-Coated Balloons for Treatment of Coronary Artery Disease

Presenter: Pier Pasquale Leone

October 28, 2024

Presentation TCT 2024

TCT 42: Sirolimus Eluting Balloon for Coronary Intervention: An All-Comers Registry

Presenter: Marco Ferrone

October 28, 2024

Presentation TCT 2024

TCT 434: Clinical Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Kiril Karamfiloff

October 28, 2024

Presentation TCT 2024

TCT 421: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in U.S. Patients Undergoing Coronary Revascularization: 2-Year Outcomes From the BIOFLOW-VII Trial

Presenter: David Kandzari

October 28, 2024

Presentation TCT 2024

A Randomized Comparison Between Selution SLR™ Sirolimus-Eluting Balloon and Plain Old Balloon Angioplasty in Patients With Distal Internal Pudendal-Penile Artery Disease and Erectile Dysfunction: The PERFECT-SELUTION First-in-Man Study

Presenter: Tzung-Dau Wang

October 28, 2024

Presentation TCT 2024

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Presenter: Kiril Karamfiloff

October 28, 2024

Presentation TCT 2024

TCT 691: Endovascular Treatment of Femoropopliteal Peripheral Arterial Disease Lesions With the Novel Sirolimus-Coated Balloons: A Meta-Analysis

Presenter: Hamza Naveed

October 28, 2024

Presentation TCT 2024

TCT 664: Simplifying Coronary Revascularization in High Bleeding Risk With SCAD or ACS: Sirolimus-DCB & SAPT

Presenter: Victor Alfonso Jimenez Diaz

October 27, 2024

Presentation TCT 2024

Magnesium-Based Resorbable Scaffold vs Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: Final 5-Year Results of the MAGSTEMI Randomized Controlled Trial

Presenter: Manel Sabate

October 27, 2024

Advertisement

Evolution of PCI – Role and Value of Drug-Eluting Balloons

LIMUS as the Drug of Choice for Drug-Eluting Balloons

SELUTION SLR™ DEB Case Example from Europe

TCT 455: Quantitative Coronary Dissection Volume After Sirolimus or Paclitaxel Coated Balloon and Lumen Changes at 6 Months: Serial OCT Sub-study of TRANSFORM-I Trial

TCT 450: Patient and Procedure Characteristics for 1000 Selution SLRTM Sirolimus-Eluting Balloon Procedures

Current DCB Landscape in the USA: Challenges and Opportunities

Sirolimus Coated Balloon Complex Cases Presentations: The TITAN RCT

Case Presentation: DEB in ISR LMCA bifurcation

Global Clinical Experience: MagicTouch SCB in Action: An overview of EASTBOURNE, PICCOLLETO VI, and TRANSFORM

TCT 44: Angiographic and Clinical Impact of Balloon Inflation Time in Percutaneous Coronary Interventions With Sirolimus-Coated Balloon: A Subanalysis of the EASTBOURNE Study

TCT 41: Paclitaxel-Coated Versus Sirolimus-Coated Balloon Angioplasty for Coronary Artery Disease: A Systematic Review and Meta-Analysis

TCT 40: Sirolimus- vs. Paclitaxel-Coated Balloons for Treatment of Coronary Artery Disease

TCT 42: Sirolimus Eluting Balloon for Coronary Intervention: An All-Comers Registry

TCT 434: Clinical Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

TCT 421: Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents in U.S. Patients Undergoing Coronary Revascularization: 2-Year Outcomes From the BIOFLOW-VII Trial

A Randomized Comparison Between Selution SLR™ Sirolimus-Eluting Balloon and Plain Old Balloon Angioplasty in Patients With Distal Internal Pudendal-Penile Artery Disease and Erectile Dysfunction: The PERFECT-SELUTION First-in-Man Study

TCT 444: Angiographic Outcomes After Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

TCT 691: Endovascular Treatment of Femoropopliteal Peripheral Arterial Disease Lesions With the Novel Sirolimus-Coated Balloons: A Meta-Analysis

TCT 664: Simplifying Coronary Revascularization in High Bleeding Risk With SCAD or ACS: Sirolimus-DCB & SAPT

Magnesium-Based Resorbable Scaffold vs Permanent Metallic Sirolimus-Eluting Stent in Patients With ST-Segment Elevation Myocardial Infarction: Final 5-Year Results of the MAGSTEMI Randomized Controlled Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content